Exploiting cancer’s Achilles’ heel
What drives innovation? For Dr. Trey Westbrook it’s a personal mission to find new treatments for invasive breast cancer.
His work focuses on the genetic mechanisms and key targets for treating triple-negative breast cancer.
Dr. Westbrook, associate professor of molecular and human genetics and of biochemistry and molecular biology at Baylor College of Medicine, recently was named the recipient of The Academy of Medicine, Engineering & Science of Texas 2015 Edith and Peter O’Donnell Award.
Watch him explain his research into the genetic culprits and drivers of triple-negative breast cancer in this video from TAMEST.
Additional Resources
Learn more about the TAMEST Edith and Peter O’Donnell Awards
Read more about Dr. Westbrook’s award
